Monitoring for Clinical Trials

Join us for an interactive introduction to best practices in preparing for and participating in clinical trial monitoring visits.

What is this offering?

Join us for an interactive introduction to best practices in preparing for and participating in clinical trial monitoring visits. During this virtual program you will learn about the purpose of monitoring and how it differs from an audit, what to expect from different types of monitoring visits, preparing for an interim visit, and tips on responding to follow-up letters and reports. Participants will engage in activities in both large and small groups. This session does not teach how to become a monitor.

Primary audience: Study team members who are involved with required monitoring visits for drug, device, or biologic clinical trials, but anyone interested in learning more about monitoring for clinical trials is welcome. This is intermediate-level training, so participants are expected to understand basic clinical trials procedures and terminology through experience or prior training.

Due to confidentiality and U-M-specific policies and procedures, this session is open to U-M employees and affiliated health systems or those who are working on a clinical trial with a U-M principal investigator.

How this advances translational science

Implementing operations that facilitate and support the quality and impact of research.